Among the most popular portfolio startups of the fund, we may highlight MicuRx Pharmaceuticals. Among the most popular fund investment industries, there are Health Care, Medical. Moreover, a startup needs to be at the age of 6-10 years to get the investment from the fund.
The usual cause for the fund is to invest in rounds with 3 partakers. Despite the GP TMT Capital, startups are often financed by Morningside Group, Devon Park BioVentures, BioVeda China Fund. The meaningful sponsors for the fund in investment in the same round are GP Healthcare Capital, 3E Bioventures. In the next rounds fund is usually obtained by Delian Capital, BioVeda China Fund.
The top activity for fund was in 2016. The fund is constantly included in less than 2 deals per year. Deals in the range of 50 - 100 millions dollars are the general things for fund.
Related Funds
| Fund Name | Location |
| Asia.com | Bedminster, New Jersey, United States |
| Axan Ventures | - |
| Forval Creative | Japan, Kanagawa Prefecture, Kawasaki |
| Groupama | France, Ile-de-France, Paris |
| Lunch Partners | New York, New York, United States |
| MDR LAB | England, London, United Kingdom |
| Off the Grid Ventures | California, San Francisco, United States |
| ProCapita HR Consultancy | - |
| QingCloud Enterprise Management | - |
| Thairm Bio | - |
Notable deals
| Company | Industry | Round Size | Date | Investors | Location |
MicuRx Pharmaceuticals | $55M | 26 Sep 2016 | Hayward, California, United States |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Full teamIndustries heatmapStages heatmapGeorgaphy breakdownCoinvestorsPortfolio analysisPerformance indexesLatest highlights
Unlock all data Latest deals
| Company | Industry | Round Size | Date | Investors | Location |
MicuRx Pharmaceuticals | $55M | 26 Sep 2016 | Hayward, California, United States |
